Let's Talk About Lung Cancer | S1, Ep2: Biomarker testing and genetically-driven lung cancers
Update: 2023-01-23
Description
Lorraine Dallas, our director of prevention, information and support, chats to consultant oncologist Dr David Gilligan and Peter Cowley, who is living with advanced stage lung cancer.
Therapies are available for some lung cancers driven by genetic mutations or rearrangements, which is why biomarker testing is so important. Peter shares his experience of diagnosis and being eligible for one of these medicines.
For more information about lung cancer and Roy Castle Lung Cancer Foundation, visit roycastle.org.
Keep up to date with the latest news by following our social media channels:
Twitter - Roy_Castle_Lung
Instagram - RoyCastleLungCancer
Facebook - Roy Castle Lung Cancer Foundation
Comments
In Channel


![Talk of Hope | S2, Ep5: Ros1ders [Catherine Paul] [Del Danaher] Talk of Hope | S2, Ep5: Ros1ders [Catherine Paul] [Del Danaher]](https://s3.castbox.fm/f0/4f/5c/23ce4ddede2a8a17711cff8b0065d28538_scaled_v1_400.jpg)


